15-min delayed · Sep 11, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Acuren Corporation, 2 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $10.00 to $15.00, a moderate spread. The average target of $12.13 sits 27% above the current $9.56. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.13 next quarter toward $0.57 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Acuren Corporation.
As of Sep, 2 of 4 firms rate TIC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TIC EPS & revenue forecast
EPS · NEXT QUARTER
$0.13
Range $0.12 – $0.16 · 4 analysts · -199% YoY
Next period, 4 analysts expect Acuren Corporation to earn $0.13 a share (range $0.12 – $0.16), versus $-0.13 a year earlier. Full-year consensus is $0.45, growing to $0.57 the year after.
REVENUE · NEXT QUARTER
$533.5M
Range $518.2M – $546.8M · 4 analysts · +5% YoY
Revenue is expected to reach $533.5M (range $518.2M – $546.8M), +5.0% year-over-year. Full-year consensus is $2.2B, rising to $2.3B next year.
Top analysts covering Acuren Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TIC.
#1
Jeff Martin
Roth MKM · Rank #255
Buy
$11.50+20.3% to target
Overall win rate
37%
+ Follow
#2
Andrew Wittmann
Baird · Rank #259
Hold
$15.00+56.9% to target
Overall win rate
36%
+ Follow
#3
JC
Joshua Chan
UBS
Buy
$12.50+30.8% to target
Coverage
—
+ Follow
#4
TS
Tomohiko Sano
JP Morgan
Hold
$11.00+15.1% to target
Coverage
—
+ Follow
#5
Stephanie Moore
Jefferies
Buy
$16.00+67.4% to target
Coverage
—
+ Follow
TIC stock forecast FAQ
What is TIC's average 12-month price target?+
The 4 analysts with a live target average $12.13 for Acuren Corporation over the next 12 months, ranging from a $15.00 high to a $10.00 low.
Is TIC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TIC?+
The Street-high target is $15.00 (Baird), and the Street-low is $10.00 (Roth Capital). The average of all 4 active targets is $12.13.
How many Wall Street analysts cover TIC?+
4 analysts have an active rating on Acuren Corporation, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering TIC?+
Among analysts who currently cover TIC, Jeff Martin of Roth MKM has the strongest overall Quantellect track record (Rank #255). Their current call is Buy with a $11.50 target.
What is Acuren Corporation's projected EPS for next quarter?+
The consensus estimate is $0.13 per share (range $0.12 – $0.16) across 4 analysts. Full-year EPS is projected at $0.45, rising to $0.57 the following year.
How much revenue is Acuren Corporation expected to report next quarter?+
Consensus revenue is $533.5M (range $518.2M – $546.8M). Full-year revenue is projected at $2.2B, growing to $2.3B next year.
Have analysts been upgrading or downgrading TIC lately?+
As of Sep, 2 of 4 firms rate TIC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TIC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
